Weekly weight fluctuates, so focus on the four-week average trend rather than any single reading
The action of SNAC is time- and concentration-dependent and is fully reversible.[] In various pharmacological studies, the dose of SNAC has been from 150 to 600 mg and it has been found that 300 mg of SNAC is the optimum dose to get maximum bioavailability
Am Heart J 2021
Why weight loss is not the end of the treatment pathway During active GLP-1 treatment, many people experience reduced appetite, fewer food thoughts, and greater control over eating
In contrast, for those on GLP-1RAs therapy for 6 months or less, the intercepts were negative for age and positive for gender, but again, the estimates for age and sex did not yield significant results, indicating a lack of influence from these variables on weight changes
We wanted to solve this problem by building a design system that we could distribute across business units and divisions